Fexmid
- Product NDC
- 55700-726
- 11-digit product format
- 557000726
- Labeler code
- 55700
- Product ID
- 55700-726_98213ac9-6309-4027-95ca-149fb0770e27
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cyclobenzaprine Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Quality Care Products, LLC
- Application
- ANDA071611
- Marketing category
- ANDA
- Marketing start
- 2019-02-15
- Marketing end
- 0000-00-00
- Substance
- CYCLOBENZAPRINE HYDROCHLORIDE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55700-726-30 | 2025-01-10 | C162847 | 48780-1 | ba0f9c33-2eb9-a910-e053-dadaa90a0b85 | e7649bf8-266d-4ef2-aaea-ae12a1f6bcd6 |
| 55700-726-60 | 2025-01-10 | C162847 | 48780-1 | ba0f9c33-2eb9-a910-e053-dadaa90a0b85 | e7649bf8-266d-4ef2-aaea-ae12a1f6bcd6 |
| 55700-726-90 | 2025-01-10 | C162847 | 48780-1 | ba0f9c33-2eb9-a910-e053-dadaa90a0b85 | e7649bf8-266d-4ef2-aaea-ae12a1f6bcd6 |
| 55700-726-30 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-2eb9-a910-e053-dadaa90a0b85 | e7649bf8-266d-4ef2-aaea-ae12a1f6bcd6 |
| 55700-726-60 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-2eb9-a910-e053-dadaa90a0b85 | e7649bf8-266d-4ef2-aaea-ae12a1f6bcd6 |
| 55700-726-90 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-2eb9-a910-e053-dadaa90a0b85 | e7649bf8-266d-4ef2-aaea-ae12a1f6bcd6 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55700-726-30 | EA - Each | 55700-726 | 65155eba-a9a1-4cf0-bce6-48f1f30f6604 | 1 | 2019-03-12 |
| 55700-726-60 | EA - Each | 55700-726 | 259033fb-635f-4177-90ec-385756debc1a | 1 | 2019-03-12 |
| 55700-726-90 | EA - Each | 55700-726 | 65500013-189b-4687-b401-af79fb737b41 | 1 | 2019-03-12 |